Annals ofPharmacology

Volume: 4 - Number: 26 - February 15, 2004

Outstanding

The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling

Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction

Nonpeptide Antagonists of AT1 Receptor for Angiotensin II Delay the Onset of Acute Respiratory Distress Syndrome

Caveolae`s biology

Caveolae: From Cell Biology to Animal Physiology

Endocrine and reproduction

Prenatal Opiate Withdrawal Activates the Chick Embryo Hypothalamic-Pituitary-Adrenal Axis and Dilates Vitelline Blood Vessels via Serotonin2 Receptors

Gastrointestinal, hepatic, pulmonary and renal pharmacology

Lithocholylcholine, a Bile Acid/Acetylcholine Hybrid, Is a Muscarinic Receptor Antagonist

Effect of Cyclosporine A on Hepatic Compensatory Growth: Role of Calcium Status

Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction

Stereoselective Metabolism of Bufuralol Racemate and Enantiomers in Human Liver Microsomes

()-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. I. In Vitro Characterization

()-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. II. In Vivo Characterization

Inflammation and immunopharmacology

Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin

Inflammation and immunopharmacology

Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia

Inflammation and immunopharmacology

Nonpeptide Antagonists of AT1 Receptor for Angiotensin II Delay the Onset of Acute Respiratory Distress Syndrome

Inflammation and Immunopharmacology

PPA250 [3-(2,4-Difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl) Phenoxy]ethoxy}-2-phenylpyridine], a Novel Orally Effective Inhibitor of the Dimerization of Inducible Nitric-Oxide Synthase, Exhibits an Anti-Inflammatory Effect in Animal Models of Chronic

Biological Activity of a Novel Nonpeptide Antagonist to the Interleukin-6 Receptor 20S,21-Epoxy-resibufogenin-3-formate

Modulators and Integrators of G Protein Signaling

Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling

Molecular patogenesis of the amyloid precursor`s

Amyloid Precursor Protein, Presenilins, and alpha-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer`s Disease

Polimerasa inhibitors

The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors